Benzinga's Top Initiations
Analysts at Baird initiated coverage on Visteon Corp (NYSE: VC) with a Outperform rating. The target price for Visteon is set to $123. Visteon shares closed at $100.30 yesterday.
Analysts at Sterne Agee CRT initiated coverage of BioPharmX Corp (NYSE: BPMX) with a Buy rating. The target price for BioPharmX is set to $3.50. BioPharmX shares closed at $1.43 yesterday.
Analysts at William Blair initiated coverage on WhiteWave Foods Co (NYSE: WWAV) with a Outperform rating. WhiteWave Foods shares closed at $45.41 yesterday.
Canaccord Genuity initiated coverage on vTv Therapeutics Inc (NASDAQ: VTVT) with a Buy rating. The target price for vTv Therapeutics is set to $15. vTv Therapeutics shares closed at $9.50 yesterday.
UBS initiated coverage on Healthways, Inc. (NASDAQ: HWAY) with a Neutral rating. The target price for Healthways is set to $13. Healthways shares closed at $11.77 yesterday.
Analysts at Argus Research initiated coverage on Gannett Co Inc (NYSE: GCI) with a Hold rating. Gannett shares closed at $13.51 yesterday.
Analysts at Redburn initiated coverage on Priceline Group Inc (NASDAQ: PCLN) with a Buy rating. Priceline Group shares closed at $1,240.37 yesterday.
Latest Ratings for VC
|Jan 2017||Raymond James||Upgrades||Market Perform||Outperform|
|Dec 2016||BMO Capital||Initiates Coverage On||Market Perform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.